List your tool

Head to head · 2026

Infermedica vs NeuroClues

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Infermedica

Clinical AI triage platform that assesses patient symptoms by chat, voice or call center and routes…

4.4Not listed

Visit Infermedica (opens Infermedica in a new tab)

NeuroClues

Eye-tracking medical device that uses AI to detect early biomarkers of Parkinson's, Alzheimer's, and multiple sclerosis

4.3Not listed

Visit NeuroClues (opens NeuroClues in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Infermedica does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Infermedica

    4.4 against 4.3

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onInfermedicaNeuroClues
Our rating4.4Better4.3
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Conversational symptom triage by chat or voice
  • Call center voice agent with structured nurse handoff
  • Pre-visit patient intake
  • Triage API for custom apps
  • Class IIb medical device certification under EU MDR
  • Portable, CE-marked Class IIa medical device for clinical eye-movement recording
  • Calibration-free patient setup using dual infrared cameras at 400 fps
  • AI-derived biomarkers benchmarked against reference ranges for clinical interpretation
  • Early-detection targeting for Parkinson's, Alzheimer's, and multiple sclerosis
  • Deployment across university hospitals and private neurology practices in seven-plus countries
Pros
  • Regulated as a medical device in the EU and UK
  • Covers chat, voice and call center channels
  • Long deployment record across 30+ countries
  • CE-marked Class IIa medical device status gives it real regulatory clearance, not only research-stage promise
  • More than €22 million raised, including a €10 million Series A, signals investor confidence
  • Aims at detection years before visible symptoms, where neurological treatment has the most impact
Cons
  • No published pricing
  • Sold to healthcare organizations, not individual patients
  • Outcome and savings figures are the company's own
  • No published pricing, and as a clinical device it is sold directly to institutions, not individuals
  • Limited so far to the European market and CE marking, without confirmed FDA clearance
  • As a diagnostic aid, findings still require a neurologist's clinical interpretation, not a standalone verdict
CompanyInfermedicaneuroClues, founded 2020

Prices come from each vendor's pricing page, last checked 20261012. Check the vendor before you buy.

FAQ

Questions people ask

Is Infermedica better than NeuroClues?

In our reviews Infermedica scores 4.4 and NeuroClues scores 4.3. The better pick depends on the job. Infermedica: Clinical AI triage platform that assesses patient symptoms by chat, voice or call center and routes them to the right level of care, certified as a Class IIb medical device under EU MDR, with intake and API products. NeuroClues: Eye-tracking medical device that uses AI to detect early biomarkers of Parkinson's, Alzheimer's, and multiple sclerosis.

Which is cheaper, Infermedica or NeuroClues?

Infermedica: see pricing. NeuroClues: see pricing.

Do Infermedica and NeuroClues have free plans?

Neither lists a free plan.

More comparisons